Anticoagulant drugs are effective in reducing mortality in COVID-19 patients, since they are effective in preventing fatal ailments related to this disease, such as strokes or heart attacks. A study led by the Spanish cardiologist Valentín Fuster at the National Center for Cardiovascular Research and the Mount Sinai Hospital in New York has confirmed that patients who are given this type of medicine have around 50% more chances of survival versus those to whom the treatment is not applied. Also, those who take blood thinners have a 31% lower chance of being intubated.
Survival of COVID-19 patients has been improved by treatments that are not effective against coronavirus
The study, published this Wednesday by The Journal of the American College of Cardiology, analyzes the autopsies of 26 deaths from COVID-19. In 11 of them it was observed that they had died from complications derived from thrombi, whether pulmonary, cardiac or cerebral. This is one of the most common complications of this disease, as explained in this article from ElDiario.es.
Blood thinners are effective because they are drugs that prevent clots from forming and prevent existing ones from getting bigger and causing collapse in veins, arteries, or the heart. Therefore, they are effective drugs to stop the mortality of the virus because it attacks many of the patients out there, forming clots inside the blood vessels.
As it is one of the most common causes of death related to COVID-19, studies had already been done to verify the effectiveness of anticoagulants. The new study confirms what was already pointed out last May with a sample of almost 3,000 patients in whom better results were observed in those to whom this type of treatment was applied. In this new study, the sample has been expanded to 4,389 positives for coronavirus in five different hospitals between the months of March and April, with results that point in the same direction.
Only 10.6% of the patients, 467 individuals, required intubation. The difference between the use of different types of anticoagulants was not significant, since those who took therapeutic anticoagulants had a 31% less chance of intubation, a percentage that decreased minimally to 28% less chance for those who received it. provided prophylactic anticoagulants.
It is important to note that these treatments are not effective against the coronavirus, but for the complications that result from the disease. The scientific community is focused on looking for an effective cure or treatment, but until then, this type of study helps us find a way to reduce the number of deaths.